English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Startup by Silicon Valley Nobel Protege Invents Compact Home Device with Blockchain Technology Capable of Detecting Coronavirus
Mar 21, 2020 21:00 HKT
Blockchain Holdings to Acquire COVID-19 Quarantine Management Product TRACEsafe
Mar 21, 2020 09:00 HKT
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
Mar 20, 2020 20:30 HKT
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials
Mar 20, 2020 06:00 HKT
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak
Mar 18, 2020 11:00 HKT
TOT BIOPHARM Announces 2019 Annual Results
Mar 18, 2020 10:06 HKT
Coronavirus Drug Development Update from NanoViricides, Inc.
Mar 16, 2020 18:15 HKT
Hua Medicine Announces 2019 Annual Results
Mar 16, 2020 13:13 HKT
ASGE Releases Recommendations for Endoscopy Units in the Era of COVID-19
Mar 14, 2020 15:00 HKT
Agilex Biolabs Announces 30% Labs Expansion and Offers Virtual Lab Tours During COVID-19 Outbreak
Mar 13, 2020 18:00 HKT
TOT BIOPHARM Garners "Listing Award of Technological Company" and "Innovative Technological Research and Development Award"
Mar 09, 2020 14:46 HKT
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
Mar 06, 2020 22:00 HKT
AIM ImmunoTech joins with ChinaGoAbroad for Ampligen China Entry against COVID-19
Feb 27, 2020 19:30 HKT
NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress
Feb 27, 2020 09:00 HKT
Captiva Verde Land Corp - Corporate Update
Feb 27, 2020 07:00 HKT
Oxford Medical Case shows Chiropractics can ease Dizziness and Neck Pain
Feb 26, 2020 14:00 HKT
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong
Feb 24, 2020 20:13 HKT
Viva Biotech Included as Constituent Stock of Hang Seng Composite Index and Other 6 Indexes, Becoming an Eligible Stock of Shenzhen-Hong Kong Stock Connect
Feb 24, 2020 07:32 HKT
The Strength and Potential of China Medical System (867.HK) Reflected in an Untenable Short Selling Attack
Feb 20, 2020 17:04 HKT
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
Feb 20, 2020 16:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: